Evidence map›Paper›PMID 35916350›Full record

ArticleGlia2022

Extracellular S100B inhibits A-type voltage-gated potassium currents and increases L-type voltage-gated calcium channel activity in dopaminergic neurons.

Eric A Bancroft, Martha De La Mora, Gauri Pandey, Sara M Zarate, Rahul Srinivasan

Open access · greenAbstract read
In one paragraph

Article in Glia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Eric A BancroftDepartment of Neuroscience & Experimental Therapeutics, Texas A&M University School of Medicine, Bryan, Texas, USA.ORCID 0000-0002-5857-7625
Martha De La MoraDepartment of Neuroscience & Experimental Therapeutics, Texas A&M University School of Medicine, Bryan, Texas, USA.
Gauri PandeyDepartment of Neuroscience & Experimental Therapeutics, Texas A&M University School of Medicine, Bryan, Texas, USA.
Sara M ZarateDepartment of Neuroscience & Experimental Therapeutics, Texas A&M University School of Medicine, Bryan, Texas, USA.
Rahul SrinivasanDepartment of Neuroscience & Experimental Therapeutics, Texas A&M University School of Medicine, Bryan, Texas, USA.ORCID 0000-0003-0237-6602
Texas A&M Health Science Center · US

Funding

Identification of mechanisms by which cytisine and estrogen inhibit ER stress and exert neuroprotection in Parkinson's diseaseR01NS115809 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SRINIVASAN, RAHUL · 2020 to 2024
$1.7M
NINDS NIH HHS R01 NS115809NINDS NIH HHS R01NS115809
6 · The paper itself

Abstract

Parkinson's disease (PD) is associated with an increase in secreted S100B within the midbrain and cerebrospinal fluid. In addition, S100B overexpression in mice accelerates the loss of substantia nigra pars compacta dopaminergic (DA) neurons, suggesting a role for this protein in PD pathogenesis. We found that in the mouse SNc, S100B labeled astrocytic processes completely envelop the somata of tyrosine hydroxylase (TH) expressing DA neurons only in male mice. These data suggest that an increase in S100B secretion by astrocytes within the midbrain could play a role in DA dysfunction during early PD. We therefore asked if acute exposure to extracellular S100B alters the activity of identified TH expressing DA neurons in primary mouse midbrain cultures. Acute exposure to 50 pM S100B specifically inhibited A-type voltage-gated potassium currents in TH

Indexed as

Parkinson DiseasePotassium Channels, Voltage-Gated4-AminopyridineAnimalsCalciumCalcium Channels, L-TypeDopaminergic NeuronsMaleMicePotassiumS100 Calcium Binding Protein beta SubunitSubstantia NigraTyrosine 3-Monooxygenase4-AminopyridineCalciumCalcium Channels, L-TypePotassiumPotassium Channels, Voltage-GatedS100b protein, mouseS100 Calcium Binding Protein beta SubunitTyrosine 3-Monooxygenaseastrocytescalcium channelsneurodegenerationParkinson's diseasepotassium channelsS100B

Identifiers

PMID35916350
PMCPMC10738449
OpenAlexW4289521762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.